VistaGen Therapeutics, Inc. Common Stock (VTGN)

Typically moves ±9.02% on earnings
EARNINGS ANALYTICS
event_upcoming Est. Next Earnings: 2026-11-10 ESTIMATED
search

VistaGen Therapeutics, Inc. Common Stock (VTGN) has a 21-report earnings history dating back to Jun 29, 2021. Its average absolute post-earnings move is ±9.02%, and 47.6% of those reactions were positive. Its largest post-earnings gain was +23.04% (Nov 10, 2022) and its largest decline was -26.85% (Feb 07, 2023). The next earnings report is predicted for 2026-11-10 (estimated).

Earnings reactions

How VTGN moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

21

Avg Abs. Movement

±9.02%

Positive %

47.6%

Negative %

52.4%

Historical Earnings Statistics

Date Timing Earnings move SEC Filing
Jun 15, 2026 ☽ POST +19.91% open_in_new
Feb 12, 2026 ☽ POST -6.79% open_in_new
Nov 13, 2025 ☽ POST -1.18% open_in_new
Aug 07, 2025 ☽ POST +8.09% open_in_new
event

Earnings Count

21

Total earnings in dataset

trending_up

Avg Abs. Movement

±9.02%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Mar 31, 2026 · SEC 13-F

View all 9 →
9
Funds holding
$415640
Total value held
Buying
6 added · 1 reduced
Blackrock, Inc.
$256322 +6.09%
State Street Corp
$69217 Held
Northern Trust Corp
$41522 Held
Prudential Financial Inc
$30347 NEW BUY
Stonex Group Inc.
$8686 +13.85%

Frequently asked about VTGN earnings

When does VistaGen Therapeutics, Inc. Common Stock report earnings next? expand_more

VistaGen Therapeutics, Inc. Common Stock (VTGN)'s next earnings date is estimated for 2026-11-10. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does VTGN stock move after earnings? expand_more

Over 21 reports, VTGN has moved an average of ±9.02% the session after earnings, closing higher 47.6% of the time.

What was VTGN's biggest post-earnings move? expand_more

VTGN's largest post-earnings gain on record was +23.04% on Nov 10, 2022, and its largest decline was -26.85% on Feb 07, 2023.

Where can I find VistaGen Therapeutics, Inc. Common Stock's SEC filings? expand_more

All of VistaGen Therapeutics, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.